Impact of hypoxia-related tumor acidosis on cytotoxicity of different chemotherapeutic drugs in vitro and in vivo

Advances in Experimental Medicine and Biology

Volumn 812, Issue , 2014, Pages 51-58

  Thews, Oliver ^a   Riemann, Anne ^a   Nowak, Martin ^b   Gekle, Michael ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Acidosis; Chemotherapy; Multi drug resistance; P Glycoprotein; Pgp expression

Indexed keywords

CISPLATIN; DAUNORUBICIN; DOCETAXEL; MULTIDRUG RESISTANCE PROTEIN; VERAPAMIL; ANTINEOPLASTIC AGENT;

ACIDITY; ACIDOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL KILLING; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; GLYCOLYSIS; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CELL HYPOXIA; METABOLISM; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ACIDOSIS; ANIMALS; ANTINEOPLASTIC AGENTS; CELL HYPOXIA; CELL LINE, TUMOR; MALE; PROSTATIC NEOPLASMS; RATS;

EID: 84905905633     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-1-4939-0620-8_7     Document Type: Article

References (14)

1. Teicher BA, Holden SA, al Achi A et al (1990) Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma. Cancer Res 50:3339–3344
2. Fang J, Nakamura H, Iyer AK (2007) Tumor-targeted induction of oxystress for cancer therapy. J Drug Target 15:475–486
3. Chaplin DJ, Horsman MR, Trotter MJ et al (1998) Therapeutic significance of microenvironmental factors. In: Molls M, Vaupel P (eds) Blood perfusion and microenvironment of human tumors. Springer, Berlin, pp 131–143
4. Teicher BA (1994) Hypoxia and drug resistance. Cancer Metastasis Rev 13:139–168
5. Sauvant C, Nowak M, Wirth C et al (2008) Acidosis induces multi-drug resistance in rat prostate cancer cells (AT1) in vitro and in vivo by increasing the activity of the p-glycoprotein via activation of p 38. Int J Cancer 123:2532–2542
6. Thews O, Gassner B, Kelleher DK et al (2006) Impact of extracellular acidity on the activity of p-glycoprotein and the cytotoxicity of chemotherapeutic drugs. Neoplasia 8:143–152
7. Di Marco A, Casazza AM, Dasdia T et al (1977) Changes of activity of daunorubicin, adriamycin and stereoisomers following the introduction or removal of hydroxyl groups in the amino sugar moiety. ChemBiol Interact 19:291–302
8. Chan LM, Lowes S, Hirst BH (2004) The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. Eur J Pharm Sci 21:25–51
9. Workman P, Aboagye EO, Balkwill F et al (2010) Guidelines for the welfare and use of animals in cancer research. Br J Cancer 102:1555–1577
10. Kalliomäki T, Hill RP (2004) Effects of tumour acidification with glucose + MIBG on the spontaneous metastatic potential of two murine cell lines. Br J Cancer 90:1842–1849
11. Schwerdt G, Freudinger R, Schuster C et al (2003) Inhibition of mitochondria prevents cell death in kidney epithelial cells by intra-and extracellular acidification. Kidney Int 63:1725–1735
12. Thews O, Dillenburg W, Fellner M et al (2010) Activation of P-glycoprotein (Pgp)-mediated drug efflux by extracellular acidosis: in vivo imaging with 68Ga-labelled PET tracer. Eur J Nucl Med Mol Imaging 37:1935–1942
13. Reichert M, Steinbach JP, Supra P et al (2002) Modulation of growth and radiochemosensitivity of human malignant glioma cells by acidosis. Cancer 95:1113–1119
14. Atema A, Buurman KJ, Noteboom E et al (1993) Potentiation of DNA-adduct formation and cytotoxicity of platinum-containing drugs by low pH. Int J Cancer 54:166–172